Susan Moran - Nov 17, 2023 Form 4 Insider Report for RayzeBio, Inc. (RYZB)

Role
Chief Medical Officer
Signature
/s/ Jeff Woodley, Attorney-in-Fact
Stock symbol
RYZB
Transactions as of
Nov 17, 2023
Transactions value $
$0
Form type
4
Date filed
11/17/2023, 06:36 PM
Previous filing
Sep 14, 2023
Next filing
Feb 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYZB Stock Option (right to buy) Award $0 +164K $0.00 164K Nov 17, 2023 Common Stock 164K $22.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant.